GnRH Associated Peptide (25-53), human

Modify Date: 2024-04-05 18:23:01

GnRH Associated Peptide (25-53), human Structure
GnRH Associated Peptide (25-53), human structure
Common Name GnRH Associated Peptide (25-53), human
CAS Number 106061-19-2 Molecular Weight 3285.60
Density N/A Boiling Point N/A
Molecular Formula C140H226N40O49S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of GnRH Associated Peptide (25-53), human


GnRH Associated Peptide (GAP) (25-53), human is the human gonadotropin-releasing hormone-associated peptide (GAP) 25-53 fragment (hGAP-25-53), can be used as immunogen to generate antiseras including MC-1, MC-2, and MC-3. GAP is joined to the luteinizing hormone-releasing hormone (LH-RH) sequence by a 3 amino acid processing site[1].

 Names

Name GnRH Associated Peptide (25-53), human

 GnRH Associated Peptide (25-53), human Biological Activity

Description GnRH Associated Peptide (GAP) (25-53), human is the human gonadotropin-releasing hormone-associated peptide (GAP) 25-53 fragment (hGAP-25-53), can be used as immunogen to generate antiseras including MC-1, MC-2, and MC-3. GAP is joined to the luteinizing hormone-releasing hormone (LH-RH) sequence by a 3 amino acid processing site[1].
Related Catalog
In Vitro GAP (10 nM; 4 h) stimulates the release of both gonadotropins in anterior pituitaries from female Sprague-Dawley rats, but inhibits the basal secretion of prolactin by ~50%, compared with inhibition levels reported for dopamin, a known prolactin-inhibiting factor[2]. GAP (0.1-10 nM; 3-4 h) inhibits prolactin secretion by 40-45%, with an IC50 value of 0.25 nM[2].

 Chemical & Physical Properties

Molecular Formula C140H226N40O49S
Molecular Weight 3285.60
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here
Related Compounds: More...
GnRH Associated Peptide (1-24), human
148943-65-1
Galanin Message Associated Peptide (25-41) amide
132567-21-6
GnRH Associated Peptide: GAP: 1-13, human
100111-07-7
Diabetes Associated Peptide Fragment 8-37 Amide
135702-23-7
KRAS G13D peptide, 25 mer
145019-94-9
C-Type Natriuretic Peptide (1-53) (human) acetate salt
141294-77-1
C-Type Natriuretic Peptide (32-53) (human, porcine, rat) acetate salt
127869-51-6
(Tyr0)-C-Type Natriuretic Peptide (32-53) (human, porcine, rat)
142878-79-3
Amylin (human) trifluoroacetate salt
122384-88-7
(2R)-2-{[(1RS,2SR)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)cyclopentyl]formamido}-3-hydroxypropanoic acid
2227696-79-7
4-{[2-(but-3-en-1-ylsulfanyl)ethyl]carbamoyl}-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoic acid
2171749-38-3
2-{1-[5-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-1H-1,2,4-triazole-3-carbonyl]piperidin-2-yl}acetic acid
2172483-74-6
2-[(2S,3S)-N-[2-(dimethylamino)ethyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylpentanamido]acetic acid
2171275-14-0
tert-butyl N-[(1S)-1-(4-sulfamoylphenyl)ethyl]carbamate
2679807-03-3
2-{N-[2-(dimethylamino)ethyl]-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4,4-difluorobutanamido}acetic acid
2171712-46-0
2-{[1-benzyl-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)piperidin-4-yl]formamido}-3-(dimethylamino)propanoic acid
2171712-82-4
1-{3-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]propanoyl}-5-hydroxypiperidine-3-carboxylic acid
2172015-06-2
5-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)but-2-enoyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine-2-carboxylic acid
2172632-75-4
(R)-3-(Trifluoromethyl)-5,6,7,7a,8,9,10,11-octahydropyrazino[1,2-d]pyrido[3,2-b][1,4]diazepine
2817669-26-2